MA46160B1 - Composition antiseptique comprenant de l’unithiol et du diméthylsulfoxyde, utilisation de la composition et procédé de traitement des plaies l’utilisant - Google Patents
Composition antiseptique comprenant de l’unithiol et du diméthylsulfoxyde, utilisation de la composition et procédé de traitement des plaies l’utilisantInfo
- Publication number
- MA46160B1 MA46160B1 MA46160A MA46160A MA46160B1 MA 46160 B1 MA46160 B1 MA 46160B1 MA 46160 A MA46160 A MA 46160A MA 46160 A MA46160 A MA 46160A MA 46160 B1 MA46160 B1 MA 46160B1
- Authority
- MA
- Morocco
- Prior art keywords
- composition
- antiseptic
- unithiol
- compositions
- dimethyl sulfoxide
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 title abstract 4
- 230000002421 anti-septic effect Effects 0.000 title abstract 4
- 206010052428 Wound Diseases 0.000 title abstract 3
- 208000027418 Wounds and injury Diseases 0.000 title abstract 3
- 229960003196 unithiol Drugs 0.000 title abstract 2
- JLVSRWOIZZXQAD-UHFFFAOYSA-N 2,3-disulfanylpropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(S)CS JLVSRWOIZZXQAD-UHFFFAOYSA-N 0.000 title 1
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 229960001126 alginic acid Drugs 0.000 abstract 1
- 235000010443 alginic acid Nutrition 0.000 abstract 1
- 229920000615 alginic acid Polymers 0.000 abstract 1
- 239000000783 alginic acid Substances 0.000 abstract 1
- 150000004781 alginic acids Chemical class 0.000 abstract 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000001147 anti-toxic effect Effects 0.000 abstract 1
- 229940030225 antihemorrhagics Drugs 0.000 abstract 1
- 229940064004 antiseptic throat preparations Drugs 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000003193 general anesthetic agent Substances 0.000 abstract 1
- 230000000025 haemostatic effect Effects 0.000 abstract 1
- 239000003589 local anesthetic agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- FGGPAWQCCGEWTJ-UHFFFAOYSA-M sodium;2,3-bis(sulfanyl)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(S)CS FGGPAWQCCGEWTJ-UHFFFAOYSA-M 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Cell Biology (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne de nouvelles compositions antiseptiques colloïdales destinées au traitement des plaies et/ou l’utilisation dans des opérations chirurgicales, lesdites compositions formant un film biodégradable élastique perméable à l’air et à l’eau sur la surface des plaies et présentant des effets antiseptiques, hémostatiques, anti-inflammatoires, de guérison des plaies, et spécialement anesthésiques et antitoxiques. Les compositions selon l’invention comprennent un hydrolysat de collagène, un ou plusieurs sels d’acide alginique et un ou plusieurs antiseptiques, et sont caractérisées en ce que ces dernières comprennent additionnellement de l’unithiol et du diméthylsulfoxyde. Les compositions selon l’invention peuvent également comprendre éventuellement un ou plusieurs agents anesthésiques, préférablement des agents anesthésiques locaux.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2017106062A RU2649790C1 (ru) | 2017-02-22 | 2017-02-22 | Антисептическая композиция, содержащая унитиол и диметилсульфоксид, применение такой композиции и способ обработки ран с ее использованием |
PCT/RU2017/000906 WO2018156052A1 (fr) | 2017-02-22 | 2017-12-05 | Composition antiseptique comprenant de l'unithiol et du diméthylsulfoxyde, utilisation de la composition et procédé de traitement des plaies l'utilisant |
Publications (2)
Publication Number | Publication Date |
---|---|
MA46160A1 MA46160A1 (fr) | 2020-06-30 |
MA46160B1 true MA46160B1 (fr) | 2020-12-31 |
Family
ID=61025035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA46160A MA46160B1 (fr) | 2017-02-22 | 2017-12-05 | Composition antiseptique comprenant de l’unithiol et du diméthylsulfoxyde, utilisation de la composition et procédé de traitement des plaies l’utilisant |
Country Status (18)
Country | Link |
---|---|
US (1) | US11213492B2 (fr) |
EP (1) | EP3585422B1 (fr) |
JP (1) | JP6725108B2 (fr) |
KR (1) | KR102096254B1 (fr) |
CN (1) | CN110198731B (fr) |
AU (1) | AU2017400651B2 (fr) |
BR (1) | BR112019016555A2 (fr) |
CA (1) | CA3054005C (fr) |
CL (1) | CL2019002260A1 (fr) |
EA (1) | EA037514B1 (fr) |
GE (1) | GEP20207137B (fr) |
MA (1) | MA46160B1 (fr) |
MX (1) | MX2019009766A (fr) |
PL (1) | PL3585422T3 (fr) |
RU (1) | RU2649790C1 (fr) |
SG (1) | SG11201903102PA (fr) |
UA (1) | UA121294C2 (fr) |
WO (1) | WO2018156052A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2017138097A (ru) * | 2017-11-01 | 2019-05-07 | Анастасия Владимировна Серебрянская | Трансдермальный терапевтический препарат |
KR102271980B1 (ko) * | 2020-11-30 | 2021-07-02 | 주식회사 피엘마이크로메드 | 콜라겐-알지네이트 창상피복재 및 이의 제조방법 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2739922A (en) | 1952-03-13 | 1956-03-27 | Herman A Shelanski | Mixtures of polymeric n-vinyl pyrrolidone and halogens |
US3761590A (en) | 1970-05-18 | 1973-09-25 | Research Corp | Silver sulfadiazine used in the treatment of burns |
GB2148901A (en) * | 1983-10-04 | 1985-06-05 | Johnson & Johnson | Protein/polysaccharide complexes |
RU2062113C1 (ru) | 1993-10-19 | 1996-06-20 | Владимир Валентинович Рыльцев | Способ получения перевязочных материалов |
RU2088234C1 (ru) | 1994-11-25 | 1997-08-27 | Институт высокомолекулярных соединений РАН | Водорастворимая бактерицидная композиция и способ ее получения |
US5928671A (en) * | 1995-04-25 | 1999-07-27 | Winthrop University Hospital | Method and composition for inhibiting bacteria |
JPH10158305A (ja) * | 1996-12-03 | 1998-06-16 | Ichimaru Pharcos Co Ltd | キトサン誘導体含有抗菌・防腐剤 |
RU2185155C2 (ru) | 2000-04-27 | 2002-07-20 | Кривошеин Юрий Семенович | Клей антисептический ранозаживляющий |
US20020091074A1 (en) * | 2000-09-20 | 2002-07-11 | Wooley Richard E. | Medical compositions, dressings and methods for treating microbial infections of skin lesions |
RU2175549C1 (ru) * | 2000-10-26 | 2001-11-10 | Закрытое акционерное общество "ТОП-ВЕТ" | Ранозаживляющий лекарственный препарат "зоодерм" |
US10117812B2 (en) * | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
WO2005107723A2 (fr) * | 2004-05-06 | 2005-11-17 | Rashid Buttar | Systemes d'administration transdermique et preparations de chelation transdermiques |
RU2284824C1 (ru) * | 2005-03-18 | 2006-10-10 | Общество с ограниченной ответственностью "Сирена" | Клей хирургический антисептический "аргакол" |
WO2006121219A1 (fr) * | 2005-05-13 | 2006-11-16 | Osaka University | Agent pour commander la transition epitheliale-mesenchymale |
RU2485938C1 (ru) * | 2011-10-25 | 2013-06-27 | Григорий Константинович Ивахнюк | Гель-основа для ранозаживляющих и косметических средств и способ его получения |
CN103505470A (zh) * | 2012-06-22 | 2014-01-15 | 江苏胜意药业有限公司 | 一种聚维酮碘溶液的生产方法 |
ES2951464T3 (es) * | 2012-12-20 | 2023-10-23 | Rajiv Bhushan | Composiciones antimicrobianas |
MY188541A (en) * | 2014-01-29 | 2021-12-21 | Vyome Therapeutics Ltd | Besifloxacin for the treatment of resistant acne |
-
2017
- 2017-02-22 RU RU2017106062A patent/RU2649790C1/ru active
- 2017-12-05 MA MA46160A patent/MA46160B1/fr unknown
- 2017-12-05 JP JP2019535389A patent/JP6725108B2/ja active Active
- 2017-12-05 AU AU2017400651A patent/AU2017400651B2/en not_active Ceased
- 2017-12-05 GE GEAP201715120A patent/GEP20207137B/en unknown
- 2017-12-05 CN CN201780083999.2A patent/CN110198731B/zh active Active
- 2017-12-05 WO PCT/RU2017/000906 patent/WO2018156052A1/fr unknown
- 2017-12-05 SG SG11201903102PA patent/SG11201903102PA/en unknown
- 2017-12-05 EA EA201991280A patent/EA037514B1/ru unknown
- 2017-12-05 US US16/480,566 patent/US11213492B2/en active Active
- 2017-12-05 EP EP17835517.8A patent/EP3585422B1/fr active Active
- 2017-12-05 BR BR112019016555-0A patent/BR112019016555A2/pt unknown
- 2017-12-05 UA UAA201907165A patent/UA121294C2/uk unknown
- 2017-12-05 PL PL17835517T patent/PL3585422T3/pl unknown
- 2017-12-05 CA CA3054005A patent/CA3054005C/fr active Active
- 2017-12-05 KR KR1020197023406A patent/KR102096254B1/ko active IP Right Grant
- 2017-12-05 MX MX2019009766A patent/MX2019009766A/es unknown
-
2019
- 2019-08-09 CL CL2019002260A patent/CL2019002260A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US11213492B2 (en) | 2022-01-04 |
CA3054005C (fr) | 2022-01-04 |
CA3054005A1 (fr) | 2018-08-30 |
KR20190098269A (ko) | 2019-08-21 |
EA201991280A1 (ru) | 2019-11-29 |
GEP20207137B (en) | 2020-07-27 |
US20210008006A1 (en) | 2021-01-14 |
KR102096254B1 (ko) | 2020-04-06 |
BR112019016555A2 (pt) | 2020-03-31 |
AU2017400651A1 (en) | 2019-07-18 |
EP3585422B1 (fr) | 2022-02-09 |
UA121294C2 (uk) | 2020-04-27 |
EP3585422A1 (fr) | 2020-01-01 |
EA037514B1 (ru) | 2021-04-06 |
RU2649790C1 (ru) | 2018-04-04 |
CL2019002260A1 (es) | 2020-01-03 |
MX2019009766A (es) | 2019-10-14 |
CN110198731B (zh) | 2023-04-21 |
PL3585422T3 (pl) | 2022-06-20 |
JP2020506165A (ja) | 2020-02-27 |
CN110198731A (zh) | 2019-09-03 |
MA46160A1 (fr) | 2020-06-30 |
WO2018156052A1 (fr) | 2018-08-30 |
JP6725108B2 (ja) | 2020-07-15 |
SG11201903102PA (en) | 2019-09-27 |
AU2017400651B2 (en) | 2019-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016003014A1 (es) | Anticuerpos monoclonales contra el inhibidor de la vía del factor tisular (tfpi) (divisional sol. n°230-11). | |
UY38403A (es) | Moduladores de la alfa-1 antitripsina | |
WO2017210267A3 (fr) | Films à base de plasma et procédés pour les fabriquer et les utiliser | |
ATE489957T1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
EA200802364A1 (ru) | Композиция для ухода за кожей и ее применение | |
CL2021000650A1 (es) | Moduladores de la expresión de pnpla3 | |
MA28935B1 (fr) | Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite | |
EA201892805A1 (ru) | Дезинфицирующее средство для рук | |
CL2007002384A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis. | |
ATE302017T1 (de) | Zusammensetzung zur behandlung von durch arterielle irrigationsdefekt gewebeschäden | |
MA46160B1 (fr) | Composition antiseptique comprenant de l’unithiol et du diméthylsulfoxyde, utilisation de la composition et procédé de traitement des plaies l’utilisant | |
CO2020015377A2 (es) | Moduladores de la expresión de apol1 | |
CO2019011265A2 (es) | Moduladores de la expresión de pcsk9 | |
BR112016003082A8 (pt) | uso da tropoelastina na produção de um medicamento para cicatrização de uma ferida ou para melhora da reepitelização de uma ferida | |
MX2020011153A (es) | Método para el tratamiento y/o prevención de queratina dañada. | |
BR112019003816A2 (pt) | composição de tratamento de enxágue dos cabelos, método para tratamento de cabelos quimicamente danificados e uso de uma composição | |
ATE538799T1 (de) | Zusammensetzungen zur behandlung von haarverlust | |
EA200801296A1 (ru) | Способ лечения метаболического синдрома | |
ES2421407T3 (es) | Agente y composición para la curación de heridas | |
DK3773615T3 (da) | Flydende sammensætning til anvendelse ved behandling af slimhinden i munden-svælget-struben-spiserøret | |
FR3088542B1 (fr) | Composition cicatrisante comprenant une eau électrolysée | |
PH12021551011A1 (en) | Compositions and methods for treating transient biofilms | |
PH12021551010A1 (en) | Compositions for treating biofilms without inducing antimicrobial resistance | |
EA201991275A1 (ru) | Антисептическая композиция, содержащая поливинилпирролидон и унитиол, и применение такой композиции | |
EA201991530A1 (ru) | Композиции и способы лечения биопленок |